デフォルト表紙
市場調査レポート
商品コード
1663459

集中型患者モニタリングシステムの世界市場:患者数別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年~2032年)

Centralized Patient Monitoring System Market, By Number of Patients, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032


出版日
ページ情報
英文 303 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
集中型患者モニタリングシステムの世界市場:患者数別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年~2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

集中型患者モニタリングシステムの市場規模は2024年に6億1,450万米ドルで、2025年から2032年にかけてCAGR 7.10%で拡大

集中型患者モニタリングシステムの市場力学

医療インフラの改善

医療インフラの改善は、集中型患者モニタリングシステムの使用と有効性を促進する上で世界的に不可欠です。医療施設では、インフラの近代化に伴い、集中モニタリング機能を実現する最先端技術への投資が頻繁に行われています。診療科間や医療提供者間のデータフローを円滑にするためには、相互運用可能なシステムの導入、電子カルテ (EHR) の統合、強力なITフレームワークの構築が必要です。こうした改善により、複数の場所で患者をリアルタイムでモニターすることが容易になり、迅速な治療と治療結果の向上が保証されます。さらに、患者の集中モニタリングに必要な高度医療機器やセンサーの導入は、医療インフラの改善によって支えられています。近代的な病院や医療施設には、生理学的データやバイタルサインを簡単に記録できる最先端のモニタリング機器が装備されるようになってきています。こうした開発により、患者データの正確性と信頼性が向上するとともに、医療従事者が迅速かつ果断に行動できるようになり、患者ケアの水準が全体的に向上しています。

集中型患者モニタリングシステム市場:主な考察

リサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約7.10%のCAGRで毎年成長すると予測されています。

患者数別では、患者数16人以下のカテゴリが2024年に最大市場シェアを示すと予測されました。

エンドユーザー別では、2024年には病院が主要セグメントでした。

地域別では、北米が2024年に収益をもたらす主要市場です。

集中型患者モニタリングシステム市場:セグメンテーション分析

世界の集中型患者モニタリングシステム市場は、患者数、エンドユーザー、地域に基づいてセグメント化されます。

患者数別に見ると、市場は患者数16人以下、17~32人、33~64人、64人超に分別されます。2024年、市場は患者数16人以下のカテゴリーが支配的でした。16人以下の患者をモニタリングするために作られたシステムの主なユーザーは、病院の専門治療室、外来部門、小さな診療所です。これらの構成では通常、少数のウェアラブル・モニターやベッドサイド・モニターとインターフェースする小型の集中型モニタリング・ステーションやソフトウェア・プラットフォームが使用されます。特定の数の患者に対して、継続的なバイタルサインのモニタリングと、危機やその他の重大な事象が発生した場合の医療専門家へのタイムリーな警告を保証する重要なモニタリング機能を提供します。

エンドユーザー別に見ると、市場は病院、外傷センター、外来手術センター、その他に分けられます。この市場では、病院が最大のセグメントを占めています。病院では集中型患者モニタリングシステムを使用して、さまざまな部門やユニットで患者のさまざまな状態をモニタリングしています。これらのシステムは、救急治療室、一般病棟、集中治療室 (ICU) 、手術室など、迅速な介入と効率的な臨床管理のために継続的なバイタルサインと患者状態のモニタリングが必要な場所で不可欠です。電子カルテ (EHR) 、遠隔測定システム、ベッドサイド・モニターはすべて、病院内の集中モニタリングステーションと統合されています。これにより、医療専門家は患者の動向を追跡し、ワークフローを最適化し、より良い患者の転帰のためにケア調整を改善することができます。

集中型患者モニタリングシステム市場:地域別分析

2024年、北米は、強力な医療システム、最先端医療技術の普及、厳格な規制環境により、集中型患者モニタリングシステムの世界市場で支配的な地位を占めています。高い医療費、技術の進歩、患者の安全性とケアの質重視が、北米、特に米国とカナダにおける集中型患者モニタリングシステム市場を牽引する主な要因です。臨床上の意思決定を改善し、ワークフローを合理化し、患者の転帰を向上させるために、これらの地域は病院、ASC、外傷センター全体で集中型モニタリングソリューションの採用の最前線にあります。これらのソリューションは、高度な遠隔測定システム、ベッドサイドモニタ、集中モニタリングステーションを統合しています。

しかし、予測期間を通じて、アジア太平洋地域は、インフラ支出の増加、医療への投資の増加、デジタルヘルス技術の使用の増加により、CAGRが最も速くなると予測されています。医療へのアクセスと質を高めるため、中国、インド、日本などの国々は遠隔医療、遠隔患者モニタリング、スマート医療プロジェクトに投資しています。リアルタイムの患者モニタリング、データ分析、遠隔医療サービスは、アジア太平洋地域の集中モニタリングシステムによって支えられており、遠方の診療所から都市部の病院まで、さまざまな医療要件に対応しています。技術統合と医療革新に重点を置くこの地域は、市場参入企業にとって、リーチを広げ、変化する医療問題に取り組もうとする大きな成長見通しを提供しています。

集中型患者モニタリングシステム市場:競合情勢

競争の激しい集中型患者モニタリングシステム業界には、数多くの重要な競合企業が存在します。市場ポジションを向上させるため、業界各社は研究開発、製品投入、戦略的提携、M&Aに注力しています。集中型患者モニタリングシステム市場の主要企業としては、フィリップスヘルスケア、Koninklijke Philips N.V.、Infinium Medical、Universal Medical Instruments、GEヘルスケアなどが挙げられます。消費者と医療の高まる需要に応えるため、これらの業界参加者も常に投資とイノベーションを求めています。例えば、2023年5月、米国食品医薬品局 (FDA) はアボット社の挿入型心臓モニター (ICM) Assert-IQTMを承認し、不整脈患者に長期モニタリングと診断評価のための新たな選択肢を提供しました。この承認により、患者を遠隔で管理・治療する医師を支援するアボット社のリンク型医療機器のラインアップが拡充されました。

最近の動向

2024年11月FDAは、GEヘルスケアのNovii+母体・胎児モニタリングシステムの34週以上の妊婦への使用拡大を承認しました。Novii+は、子宮活動、母体の心拍数、胎児の心拍数を非侵襲的に測定・表示することで、入院中の患者に快適さと機動性を提供します。

2023年1月SenetとTelli Healthは、初のLoRaWAN対応遠隔患者モニタリング (RPM) 装置を発表しました。医療従事者が、先住民コミュニティなど、十分なサービスを受けられない遠隔地の患者により多く接触できるようにすることで、この技術は医療の公平性と包括性を向上させ、将来のスマートホーム・サービスの基礎を築いています。

目次

第1章 集中型患者モニタリングシステム市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 集中型患者モニタリングシステムの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 集中型患者モニタリングシステム市場:産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し:マッピング
  • 規制体制の分析

第5章 集中型患者モニタリングシステム市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 集中型患者モニタリングシステムの市場情勢

  • 集中型患者モニタリングシステムの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 集中型患者モニタリングシステム市場:患者数別

  • 概要
    • セグメント別シェア分析:患者数別
    • 患者数16人以下
    • 患者数17~32人
    • 患者数33~64人
    • 患者数64人超

第8章 集中型患者モニタリングシステム市場:エンドユーザー別

  • 概要
    • セグメント別シェア分析:エンドユーザー別
    • 病院
    • 外傷センター
    • 外来手術センター
    • その他

第9章 集中型患者モニタリングシステム市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析:集中型患者モニタリングシステム業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Philips Healthcare
    • Koninklijke Philips NV
    • Infinium Medical
    • Universal Medical Instruments
    • GE Healthcare
    • Abbott Laboratories
    • Nihon Kohden Corporation
    • Nihon Kohden
    • Sunray
    • Mediana
    • MindRay
    • Criticare Systems Inc.
    • Honeywell International Inc.
    • Others

第11章 AnalystViewの全方位的分析

目次
Product Code: ANV4634

REPORT HIGHLIGHT

Centralized Patient Monitoring System Market size was valued at US$ 614.5 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Centralized patient monitoring systems are made up of a network of interconnected medical equipment and software that make it possible to continuously monitor and gather vital signs and other pertinent information from patients. Healthcare professionals can access real-time patient data using these technologies, identify important changes, and make prompt therapeutic decisions. Healthcare providers can increase productivity, monitor more patients at once, and improve patient outcomes by centralizing patient data. The growing demand for remote patient monitoring, improvements in medical technology, and an increased emphasis on enhancing patient outcomes are all driving the market for centralized patient monitoring systems. Among the many advantages of centralized patient monitoring systems are ongoing patient observation, early anomaly identification, and prompt intervention. However, obstacles like interoperability problems, data security concerns, and the demand for qualified healthcare workers could impede the centralized patient monitoring systems industry expansion. Nevertheless, the market offers chances for manufacturers, healthcare providers, and tech developers to create cutting-edge centralized patient monitoring systems and revolutionize the way healthcare is delivered.

Centralized Patient Monitoring System Market- Market Dynamics

Improved Healthcare Infrastructure

Globally, improved healthcare infrastructure is essential to promoting the use and effectiveness of centralized patient monitoring systems. Healthcare facilities frequently make investments in cutting-edge technologies that enable centralized monitoring capabilities as they modernize their infrastructure. In order to facilitate data flow between departments and healthcare providers, this entails putting in place interoperable systems, integrating electronic health records (EHRs), and building strong IT frameworks. These improvements make it easier to monitor patients in real-time across several locations, guaranteeing prompt treatments and improved therapeutic results. Additionally, the deployment of advanced medical equipment and sensors required for centralized patient monitoring is supported by improved healthcare infrastructure. Modern hospitals and healthcare facilities are increasingly outfitted with cutting-edge monitoring devices that can easily record physiological data and vital signs. These developments improve patient data's accuracy and dependability while also empowering medical personnel to act quickly and decisively, which raises the standard of patient care overall.

Centralized Patient Monitoring System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on the number of patients segmentation, the <16 number of patients category was predicted to show the maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Centralized Patient Monitoring System Market- Segmentation Analysis:

The Global Centralized Patient Monitoring System Market is segmented on the basis of Number of Patients, End-user, and Region.

On the basis of number of patients, the market is segregated into <16 number of patients, 17-32 number of patients, 33-64 number of patients, and >64 number of patients. In 2024, the market was dominated by the <16 number of patients category. Hospital-specialized care units, outpatient departments, and tiny clinics are the main users of systems made for monitoring fewer than 16 patients. These configurations usually make use of small, centralized monitoring stations or software platforms that interface with a small number of wearables or bedside monitors. For a specific number of patients, they offer crucial monitoring capabilities that guarantee ongoing vital sign surveillance and timely alerting of medical professionals in the event of crises or other significant occurrences.

Based on end-user, the market is divided into Hospitals, Trauma Centers, Ambulatory Surgical centers, and Others. In this market, hospitals make up the largest segment. They use centralized patient monitoring systems to monitor a variety of patient statuses in different departments and units. These systems are essential in emergency rooms, general wards, intensive care units (ICUs), and operating theatres where ongoing vital signs and patient status monitoring are necessary for prompt intervention and efficient clinical management. Electronic health records (EHRs), telemetry systems, and bedside monitors are all integrated with centralized monitoring stations in hospitals. This allows medical professionals to track patient trends, optimize workflow, and improve care coordination for better patient outcomes.

Centralized Patient Monitoring System Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Centralized Patient Monitoring Systems, distinguished by strong healthcare systems, widespread use of cutting-edge medical technology, and strict regulatory environments. High healthcare costs, technology advancements, and a focus on patient safety and care quality are the main factors driving the market for centralized patient monitoring systems in North America, especially in the US and Canada. In order to improve clinical decision-making, streamline workflow, and enhance patient outcomes, these regions are at the forefront of the adoption of centralized monitoring solutions across hospitals, ASCs, and trauma centres. These solutions integrate advanced telemetry systems, bedside monitors, and centralized monitoring stations.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by growing infrastructure spending, increased investments in healthcare, and the growing use of digital health technologies. To increase access to and the quality of healthcare, nations like China, India, and Japan are investing in telemedicine, remote patient monitoring, and smart healthcare projects. Real-time patient monitoring, data analytics, and telemedicine services are supported by centralized monitoring systems in Asia Pacific, which serve a range of healthcare requirements from distant clinics to urban hospitals. The region's emphasis on technology integration and healthcare innovation offers significant growth prospects for market participants looking to broaden their reach and tackle changing healthcare issues.

Centralized Patient Monitoring System Market- Competitive Landscape:

There are a number of important competitors in the fiercely competitive centralized patient monitoring system industry. To improve their market position, companies in the industry concentrate on R&D, product launches, strategic alliances, and mergers and acquisitions. Among the leading companies in the market for centralized patient monitoring systems are Philips Healthcare, Koninklijke Philips N.V., Infinium Medical, Universal Medical Instruments, and GE Healthcare, among others. In order to meet the growing demands of consumers and healthcare, these industry participants are also always looking for investments and innovations. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) approved Abbott's Assert-IQTM insertable cardiac monitor (ICM), providing patients with irregular heartbeats with a new alternative for long-term monitoring and diagnostic evaluation. With this approval, Abbott's line of linked medical devices that can assist physicians in remotely managing and treating patients is expanded.

Recent Development

November 2024: The FDA has approved GE HealthCare's expanded use of the Novii+ maternal and fetal monitoring system for expectant mothers who are 34 weeks or more along. Novii+ gives patients comfort and mobility in the hospital by noninvasively measuring and displaying uterine activity, maternal heart rate, and fetal heart rate.

January 2023: Senet and Telli Health introduced the first LoRaWAN-enabled remote patient monitoring (RPM) devices. By enabling healthcare practitioners to contact more patients in underserved and remote places, such as indigenous communities, this technology will improve healthcare fairness and inclusivity and lay the groundwork for future smart home services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Philips Healthcare
  • Koninklijke Philips N.V.
  • Infinium Medical
  • Universal Medical Instruments
  • GE Healthcare
  • Abbott Laboratories
  • Nihon Kohden Corporation
  • Nihon Kohden
  • Sunray
  • Mediana
  • MindRay
  • Criticare Systems Inc.
  • Honeywell International Inc.
  • Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY NUMBER OF PATIENTS- MARKET ANALYSIS, 2019 - 2032

  • <16 number of patients
  • 17-32 number of patients
  • 33-64 number of patients
  • >64 number of patients

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Trauma Centers
  • Ambulatory Surgical centers
  • Others

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Centralized Patient Monitoring System Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Centralized Patient Monitoring System Market Snippet by Number of Patients
    • 2.1.2. Centralized Patient Monitoring System Market Snippet by End-user
    • 2.1.3. Centralized Patient Monitoring System Market Snippet by Country
    • 2.1.4. Centralized Patient Monitoring System Market Snippet by Region
  • 2.2. Competitive Insights

3. Centralized Patient Monitoring System Key Market Trends

  • 3.1. Centralized Patient Monitoring System Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Centralized Patient Monitoring System Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Centralized Patient Monitoring System Market Opportunities
  • 3.4. Centralized Patient Monitoring System Market Future Trends

4. Centralized Patient Monitoring System Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Centralized Patient Monitoring System Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Centralized Patient Monitoring System Market Landscape

  • 6.1. Centralized Patient Monitoring System Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Centralized Patient Monitoring System Market - By Number of Patients

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Number of Patients, 2024 & 2032 (%)
    • 7.1.2. <16 number of patients
    • 7.1.3. 17-32 number of patients
    • 7.1.4. 33-64 number of patients
    • 7.1.5. >64 number of patients

8. Centralized Patient Monitoring System Market - By End-user

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Trauma Centers
    • 8.1.4. Ambulatory Surgical centers
    • 8.1.5. Others

9. Centralized Patient Monitoring System Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Centralized Patient Monitoring System Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Centralized Patient Monitoring System Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Centralized Patient Monitoring System Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Centralized Patient Monitoring System Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Centralized Patient Monitoring System Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Number of Patients, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Centralized Patient Monitoring System Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Philips Healthcare
    • 10.2.2. Koninklijke Philips N.V.
    • 10.2.3. Infinium Medical
    • 10.2.4. Universal Medical Instruments
    • 10.2.5. GE Healthcare
    • 10.2.6. Abbott Laboratories
    • 10.2.7. Nihon Kohden Corporation
    • 10.2.8. Nihon Kohden
    • 10.2.9. Sunray
    • 10.2.10. Mediana
    • 10.2.11. MindRay
    • 10.2.12. Criticare Systems Inc.
    • 10.2.13. Honeywell International Inc.
    • 10.2.14. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us